This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Navelbine (Vinorelbine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (108)
Death (23)
Life Threatening Events (2)
Disability (1)
Reports by Reaction Type
Febrile Neutropenia (10),
Confusional State (8),
Tachycardia (8),
Tongue Neoplasm Malignant Stage Unspecified (8),
Diarrhoea (7),
Neoplasm Progression (6),
Pyrexia (6),
Pleural Effusion (6),
Cardiotoxicity (6),
Neutropenia (6),
Chills (5),
White Blood Cell Count Decreased (5)
Below are a few examples of reports where side effects / adverse reactions may be related to Navelbine (Vinorelbine). For a complete list or a specific selection of reports, please use the links above.
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from China on 2012-08-23
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Myalgia, Bone Pain, Intestinal Obstruction
Drug(s) suspected as cause:
Navelbine
Indication: Neoplasm Malignant
Start date: 2009-11-03
Xeloda
Administration route: Oral
Indication: Neoplasm Malignant
Start date: 2009-11-03
End date: 2009-11-08
Possible Navelbine side effects in 77 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24
Patient: 77 year old male
Reactions: Joint Instability, Myalgia, Parkinson's Disease, Dizziness, Dysaesthesia, Fall, Paraesthesia
Drug(s) suspected as cause:
Atorvastatin
Dosage: 40 mg, 1x/day
Administration route: Oral
End date: 2012-01-04
Carboplatin
Dosage: first cycle, day 1
Indication: Lung Neoplasm Malignant
Start date: 2011-01-01
Carboplatin
Dosage: second cycle
Start date: 2011-12-14
End date: 2011-12-14
Navelbine
Dosage: second cycle
Start date: 2011-12-14
End date: 2011-12-21
Navelbine
Dosage: first cycle, days 1 and 8
Indication: Lung Neoplasm Malignant
Start date: 2011-01-01
Possible Navelbine side effects in 64 year old female
Reported by a individual with unspecified qualification from Italy on 2012-07-24
Patient: 64 year old female
Reactions: Diarrhoea, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 40 mg unk, iv
Indication: Lung Neoplasm Malignant
Start date: 2011-06-08
End date: 2011-06-09
Navelbine
Dosage: 37.5 mg, unk, iv
Indication: Lung Neoplasm Malignant
Start date: 2011-06-08
End date: 2011-06-15
Other drugs received by patient: Glutathione Sodiuim; Desamethasone Fost
Possible Navelbine side effects in female
Reported by a consumer/non-health professional from France on 2012-07-10
Patient: female
Reactions: Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arimidex
Administration route: Oral
Start date: 2008-01-01
End date: 2009-02-01
Aromasin
Administration route: Oral
Start date: 2006-11-01
End date: 2007-02-01
Cyclophosphamide
Start date: 2004-12-03
End date: 2005-02-02
Cyclophosphamide
Administration route: Oral
Start date: 2011-02-01
Doxorubicin HCL
Start date: 2007-11-27
End date: 2009-11-05
Epirubicin Hydrochloride
Start date: 2004-12-03
End date: 2005-05-02
Estracyt / 00327002 /
Start date: 2009-12-03
End date: 2011-01-01
Faslodex / 01503001 /
Administration route: Oral
Start date: 2007-02-01
End date: 2007-05-01
Femara
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-01
Fluorouracil
Start date: 2004-12-03
End date: 2005-02-02
Navelbine
Start date: 2007-07-01
End date: 2007-11-01
Navoban
Administration route: Oral
Start date: 2007-07-01
End date: 2007-11-01
Taxotere
Start date: 2005-03-08
End date: 2005-04-19
Xeloda
Administration route: Oral
Start date: 2007-08-01
End date: 2007-11-01
Possible Navelbine side effects in 66 year old female
Reported by a consumer/non-health professional from United States on 2012-07-10
Patient: 66 year old female
Reactions: Metastasis, Malaise, Tumour Marker Increased, Drug Ineffective, Neoplasm Progression
Drug(s) suspected as cause:
Avastin
Indication: Product Used FOR Unknown Indication
Herceptin
Herceptin
Indication: Breast Cancer Metastatic
Navelbine
Navelbine
Dosage: freq: every other week
Indication: Breast Cancer
Possible Navelbine side effects in 903 month old female
Reported by a physician from France on 2012-07-05
Patient: 903 month old female
Reactions: Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arimidex
Administration route: Oral
Indication: Breast Cancer
Start date: 2008-01-01
End date: 2009-02-01
Aromasin
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-11-01
End date: 2007-02-01
Cyclophosphamide
Start date: 2004-12-03
End date: 2005-05-02
Cyclophosphamide
Indication: Breast Cancer
Start date: 2011-02-01
Cyclophosphamide
Start date: 2011-08-02
Doxorubicin HCL
Dosage: 17 courses of chemotherapy
Indication: Breast Cancer
Start date: 2007-11-27
End date: 2009-11-05
Epirubicin Hydrochloride
Dosage: 4 courses of chemotherapy
Indication: Breast Cancer
Start date: 2004-12-03
End date: 2005-05-02
Estracyt
Administration route: Oral
Indication: Breast Cancer
Start date: 2009-12-03
End date: 2011-01-01
Faslodex
Indication: Breast Cancer
Start date: 2007-02-01
End date: 2007-05-01
Femara
Administration route: Oral
Indication: Breast Cancer
Start date: 2005-04-01
End date: 2006-11-01
Fluorouracil
Dosage: 4 courses of chemotherapy
Indication: Breast Cancer
Start date: 2004-12-03
End date: 2005-02-02
Navelbine
Dosage: 4 courses of chemotherapy 90 mg from day 1 to day 8
Indication: Breast Cancer
Start date: 2007-07-01
End date: 2007-11-01
Navoban
Dosage: 4 courses of chemotherapy
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-07-01
End date: 2007-11-01
Taxotere
Dosage: 3 courses of chemotherapy
Indication: Breast Cancer
Start date: 2005-03-08
End date: 2005-04-19
Xeloda
Dosage: 4 courses of chemotherapy
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-08-01
End date: 2007-11-01
Possible Navelbine side effects in 64 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-03
Patient: 64 year old female
Reactions: Diarrhoea, Febrile Neutropenia, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 40 mg unk iv
Indication: Lung Neoplasm Malignant
Start date: 2011-06-08
End date: 2011-06-09
Navelbine
Dosage: 37.5 mg unk iv
Indication: Lung Neoplasm Malignant
Start date: 2011-06-08
End date: 2011-06-15
Other drugs received by patient: Glutathione Sodium; Desametasone Fosf
Possible Navelbine side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-03
Patient: 65 year old male
Reactions: Pulmonary Embolism
Drug(s) suspected as cause:
Cisplatin
Indication: Lung Adenocarcinoma
Navelbine
Indication: Lung Adenocarcinoma
Possible Navelbine side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-03
Patient: 61 year old male
Reactions: Hypersensitivity, Pleural Effusion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Navelbine
Other drugs received by patient: Carvedilol; Tarceva; Rocaltrol; Candesartan Cilexetil; Ticlopidine HCL; Rabeprazole Sodium; Sevelamer Hydrochloride; Aldomet; Kalimate; Calcium Lactate; Glakay
Possible Navelbine side effects in
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-03
Patient:
Reactions: Haemoptysis
Drug(s) suspected as cause:
Navelbine
Other drugs received by patient: Bevacizumab; Cisplatin
Possible Navelbine side effects in 75 year old female
Reported by a physician from France on 2012-07-03
Patient: 75 year old female
Reactions: Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arimidex
Dosage: 1 df, 1x/day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2008-01-01
End date: 2009-02-01
Aromasin
Dosage: 1 df, 1x/day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2006-11-01
End date: 2007-02-01
Cyclophosphamide
Dosage: unk
Start date: 2011-08-02
Cyclophosphamide
Dosage: 4 cycles
Indication: Breast Cancer Metastatic
Start date: 2004-12-03
End date: 2005-02-02
Doxorubicin HCL
Dosage: 8 courses
Indication: Breast Cancer Metastatic
Start date: 2007-11-27
End date: 2008-06-24
Doxorubicin HCL
Dosage: 9 courses
Start date: 2009-02-19
End date: 2009-11-05
Epirubicin Hydrochloride
Dosage: 4 cycles
Indication: Breast Cancer Metastatic
Start date: 2004-12-03
End date: 2005-05-02
Estracyt
Dosage: 2 df, 2x/day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2009-12-03
End date: 2011-01-01
Faslodex
Dosage: unk
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-02-01
End date: 2007-05-01
Femara
Dosage: 1 df, 1x/day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2005-04-01
End date: 2006-11-01
Fluorouracil
Dosage: 4 cycles
Indication: Breast Cancer Metastatic
Start date: 2004-12-03
End date: 2005-02-02
Navelbine
Dosage: 90 mg, 4 courses, cyclic, day 1-8
Indication: Breast Cancer Metastatic
Start date: 2007-07-01
End date: 2007-11-01
Navoban
Dosage: 4 cycles
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-07-01
End date: 2007-11-01
Taxotere
Dosage: 3 cycles
Indication: Breast Cancer Metastatic
Start date: 2005-03-08
End date: 2005-04-19
Xeloda
Dosage: 4 cycles
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-08-01
End date: 2007-11-01
Possible Navelbine side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-03
Patient: 71 year old male
Reactions: Pneumonia, Cardio-Respiratory Arrest, Haemoptysis, Platelet Count Decreased, Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Navelbine
Other drugs received by patient: Dexamethasone Sodium Phosphate; Magmitt; Epinastine Hydrochloride
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-02
Patient: female
Reactions: Drug Intolerance, Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arimidex
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-01
End date: 2009-02-01
Aromasin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-11-01
End date: 2007-02-01
Cyclophosphamide
Dosage: 14 days on 21 days
Indication: Breast Neoplasm
Start date: 2011-02-01
Doxorubicin HCL
Dosage: 9 courses
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-19
End date: 2009-11-05
Doxorubicin HCL
Dosage: 8 courses
Start date: 2007-11-27
End date: 2008-06-24
Estracyt
Administration route: Oral
Start date: 2009-12-03
End date: 2011-01-01
Estracyt
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-08-02
Faslodex
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2007-02-01
End date: 2007-05-01
Femara
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2006-11-01
Navelbine
Dosage: at day 1 and day 8 per course 4 course
Indication: Metastases To Pleura
Start date: 2007-07-01
End date: 2007-11-01
Navoban
Dosage: 4 courses
Administration route: Oral
Indication: Metastases To Pleura
Start date: 2007-07-01
End date: 2007-11-01
Xeloda
Dosage: 4 courses
Administration route: Oral
Indication: Metastases To Pleura
Start date: 2007-07-01
End date: 2007-11-01
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-02
Patient: female
Reactions: Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arimidex
Administration route: Oral
Start date: 2008-01-01
End date: 2009-02-01
Aromasin
Administration route: Oral
Start date: 2006-11-01
End date: 2007-02-01
Cyclophosphamide
Start date: 2004-12-03
End date: 2005-02-02
Doxorubicin HCL
Start date: 2007-11-27
End date: 2009-11-05
Epirubicin Hydrochloride
Start date: 2004-12-03
End date: 2005-05-02
Estracyt / 00327002 /
Start date: 2009-12-03
End date: 2011-01-01
Femara
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-01
Fluorouracil
Start date: 2004-12-03
End date: 2005-02-02
Fulvestrant
Administration route: Oral
Start date: 2007-02-01
End date: 2007-05-01
Navelbine
Start date: 2007-07-01
End date: 2007-11-01
Navoban
Administration route: Oral
Start date: 2007-07-01
End date: 2007-11-01
Taxotere
Start date: 2005-03-08
End date: 2005-04-19
Xeloda
Administration route: Oral
Start date: 2007-08-01
End date: 2007-11-01
Possible Navelbine side effects in 75 year old female
Reported by a physician from France on 2012-06-29
Patient: 75 year old female
Reactions: Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arimidex
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2008-01-01
End date: 2009-02-01
Aromasin
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2006-11-01
End date: 2007-02-01
Cyclophosphamide
Indication: Breast Cancer Metastatic
Start date: 2004-12-03
End date: 2005-02-02
Doxorubicin HCL
Indication: Breast Cancer Metastatic
Start date: 2007-11-27
End date: 2009-11-05
Epirubicin Hydrochloride
Indication: Breast Cancer Metastatic
Start date: 2004-12-03
End date: 2005-05-02
Estracyt
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2009-12-03
Faslodex
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-02-01
End date: 2007-05-01
Femara
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2005-04-01
End date: 2006-11-01
Fluorouracil
Indication: Breast Cancer Metastatic
Start date: 2004-12-03
End date: 2005-02-02
Navelbine
Indication: Breast Cancer Metastatic
Start date: 2007-07-01
End date: 2007-11-01
Navoban
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-07-01
End date: 2007-11-01
Taxotere
Indication: Breast Cancer Metastatic
Start date: 2005-03-08
End date: 2005-04-19
Xeloda
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-11-01
End date: 2007-11-01
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-28
Patient: female
Reactions: Lymphadenopathy, Tongue Disorder, Bronchial Disorder, General Physical Health Deterioration, Metastases To Pleura, Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arimidex
Dosage: 1 df, daily
Administration route: Oral
Start date: 2008-01-01
End date: 2009-02-01
Cyclophosphamide
Start date: 2004-12-03
Cyclophosphamide
Start date: 2011-02-01
Cyclophosphamide
Start date: 2011-02-02
Doxorubicin HCL
Start date: 2007-11-27
End date: 2008-06-24
Doxorubicin HCL
Start date: 2009-02-19
End date: 2009-11-05
Epirubicin Hydrochloride
Start date: 2004-12-02
End date: 2005-02-02
Estracyt
Dosage: 2 df, twice daily
Administration route: Oral
Start date: 2009-12-03
End date: 2011-01-01
Exemestane
Dosage: 1 df, daily
Administration route: Oral
Start date: 2006-11-01
End date: 2007-02-01
Faslodex
Administration route: Oral
Start date: 2007-02-01
End date: 2007-05-01
Femara
Dosage: 1 df, daily
Start date: 2005-04-01
End date: 2006-11-01
Fluorouracil
Start date: 2004-12-03
End date: 2005-02-02
Navelbine
Dosage: 90 mg, unk
Start date: 2007-07-01
End date: 2007-11-01
Navoban
Administration route: Oral
Start date: 2007-07-01
End date: 2007-11-01
Xeloda
Administration route: Oral
Start date: 2007-08-01
End date: 2007-11-01
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-28
Patient: female
Reactions: General Physical Condition Abnormal, Drug Intolerance, Recurrent Cancer, Toxicity To Various Agents, Tongue Neoplasm Malignant Stage Unspecified, Metastases To Skin, Treatment Failure, Metastases To Pleura, Metastases To Bone, Metastases To Lung
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arimidex
Dosage: 1 dosage forms;
Administration route: Oral
Indication: Breast Cancer
Start date: 2008-01-01
End date: 2009-02-01
Aromasin
Dosage: 1 dosage forms;
Administration route: Oral
Indication: Breast Cancer
Start date: 2006-11-01
End date: 2007-02-01
Cyclophosphamide
Dosage: 4 courses
Indication: Breast Cancer
Start date: 2004-12-03
End date: 2005-02-02
Doxorubicin HCL
Dosage: 17 courses
Indication: Breast Cancer
Start date: 2007-08-27
End date: 2009-11-05
Epirubicin Hydrochloride
Dosage: 4 courses
Indication: Breast Cancer
Start date: 2004-12-03
End date: 2005-05-02
Estracyt
Dosage: 4 dosage forms;
Administration route: Oral
Indication: Breast Cancer
Start date: 2009-12-03
End date: 2011-01-01
Faslodex
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-02-01
End date: 2007-05-01
Femara
Dosage: 1 dosage forms;
Administration route: Oral
Indication: Breast Cancer
Start date: 2005-04-01
End date: 2006-11-01
Fluorouracil
Dosage: 4 courses
Indication: Breast Cancer
Start date: 2004-12-03
End date: 2005-02-02
Navelbine
Dosage: 90mg on day 1 and 8, 4 courses
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-07-01
End date: 2007-11-01
Navoban
Dosage: 4 courses
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-07-01
End date: 2007-11-01
Taxotere
Dosage: 3 courses
Indication: Breast Cancer
Start date: 2005-03-08
End date: 2005-04-19
Xeloda
Dosage: 4 courses
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-08-01
End date: 2007-11-01
Possible Navelbine side effects in 64 year old female
Reported by a physician from Italy on 2012-06-27
Patient: 64 year old female
Reactions: Diarrhoea, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 50mg/100ml (cyclical)
Indication: Lung Adenocarcinoma
Start date: 2011-06-08
End date: 2011-06-09
Navelbine
Dosage: 37.5 (10 mg/ml,cyclical)
Indication: Lung Adenocarcinoma
Start date: 2011-06-08
End date: 2011-06-15
Other drugs received by patient: Desametasone Fosfato Hospira; Glutatione Sodico
Possible Navelbine side effects in 63 year old male
Reported by a physician from France on 2012-06-25
Patient: 63 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cisplatin
Dosage: 145 mg, cyclic
Indication: Neoplasm Malignant
Start date: 2008-02-01
End date: 2008-05-01
Navelbine
Dosage: 55 mg, day 1 to day 8
Indication: Neoplasm Malignant
Start date: 2008-02-01
End date: 2008-05-01
Tarceva
Dosage: 25 mg, uid/qd
Administration route: Oral
Indication: Neoplasm Malignant
Start date: 2008-10-01
End date: 2012-04-28
Possible Navelbine side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-25
Patient: male
Reactions: Eyelid Oedema, Face Oedema, Chills, Tachycardia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemzar
Indication: Hodgkin's Disease
Start date: 2012-04-30
Ifosfamide
Indication: Hodgkin's Disease
Navelbine
Indication: Hodgkin's Disease
Start date: 2012-04-30
Possible Navelbine side effects in 76 year old male
Reported by a physician from United Kingdom on 2012-06-22
Patient: 76 year old male, weighing 96.0 kg (211.2 pounds)
Reactions: Constipation, Ileus Paralytic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-20
Navelbine
Dosage: 55mg/m2
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-20
Possible Navelbine side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-21
Patient: female
Reactions: White Blood Cell Count Decreased, Back Pain, Pain in Extremity, Therapeutic Response Unexpected, Palmar-Plantar Erythrodysaesthesia Syndrome, Headache, Metastases To Spine, Musculoskeletal Stiffness, Brain Neoplasm
Drug(s) suspected as cause:
Herceptin
Dosage: first therapy of herceptin
Herceptin
Start date: 2012-01-01
Herceptin
Indication: Breast Cancer
Start date: 2012-01-12
Herceptin
Start date: 2012-01-01
Herceptin
Dosage: reduction frequency
Start date: 2012-01-01
Herceptin
Start date: 2012-01-01
Navelbine
Indication: Breast Cancer
Navelbine
Dosage: dose reduce three weeks on adnone week off
Taxol
Indication: Breast Cancer
Tykerb
Indication: Breast Cancer
Start date: 2009-12-01
Xeloda
Dosage: two week on and one week off.
Indication: Breast Cancer
Start date: 2009-12-01
Xeloda
Start date: 2010-11-01
Possible Navelbine side effects in female
Reported by a physician from Germany on 2012-06-20
Patient: female
Reactions: Tinnitus, Visual Impairment, Dizziness
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
Herceptin
Dosage: 11 cycle
Start date: 2012-04-24
Navelbine
Indication: Breast Cancer
End date: 2011-12-01
Other drugs received by patient: Jodid; Junik; Serevent; Eunova; Lisinopril; Trimipramine Maleate; Acetaminophen
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-15
Patient: female
Reactions: Spinal Cord Compression, Thrombophlebitis, Injection Site Pain
Drug(s) suspected as cause:
Carboplatin
Dosage: intravenous (not otherwise specified)
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-24
Navelbine
Dosage: intravenous (not otherwise specified)
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-24
Possible Navelbine side effects in 72 year old female
Reported by a physician from Israel on 2012-06-13
Patient: 72 year old female
Reactions: Multi-Organ Failure, Renal Failure, Pneumonia, Sepsis, Atrial Fibrillation, Pyrexia, Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Navelbine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Trastuzumab
Indication: Breast Cancer
Possible Navelbine side effects in female
Reported by a physician from United Kingdom on 2012-06-08
Patient: female
Reactions: Thrombophlebitis
Drug(s) suspected as cause:
Carboplatin
Indication: non-Small Cell Lung Cancer
Navelbine
Indication: non-Small Cell Lung Cancer
Possible Navelbine side effects in 14 year old female
Reported by a physician from United States on 2012-06-07
Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Atelectasis, Hypotension, Pleural Effusion, Febrile Neutropenia, Hypoxia, Pneumonitis, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: day 1 over 30-60 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-14
Navelbine
Dosage: days 1 and 8, over 6-10 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-01
End date: 2012-02-21
Temsirolimus
Dosage: days 1, 8 and 15 over 30-60 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-28
Possible Navelbine side effects in 45 year old female
Reported by a physician from Taiwan, Province of China on 2012-06-06
Patient: 45 year old female
Reactions: Pleural Effusion, Metastases To Bone, Metastases To Central Nervous System
Drug(s) suspected as cause:
Herceptin
Start date: 2009-06-08
End date: 2009-09-08
Herceptin
Start date: 2009-09-29
End date: 2010-07-08
Herceptin
Indication: Breast Cancer Metastatic
Start date: 2009-06-01
End date: 2009-06-01
Navelbine
Administration route: Oral
Start date: 2009-12-29
End date: 2010-02-09
Navelbine
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2009-12-21
End date: 2009-12-21
Taxotere
Start date: 2009-09-29
End date: 2009-12-01
Taxotere
Indication: Breast Cancer Metastatic
Start date: 2009-06-01
End date: 2009-07-27
Xeloda
Indication: Breast Cancer Metastatic
Start date: 2010-03-02
End date: 2010-07-20
Possible Navelbine side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06
Patient: female, weighing 12.7 kg (27.9 pounds)
Reactions: Mucosal Inflammation, Fungaemia, Febrile Neutropenia, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bevacizumab
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Cyclophosphamide
Dosage: 11 mg
Administration route: Oral
Indication: Rhabdomyosarcoma
Start date: 2012-03-01
Dactinomycin
Dosage: day 1 of cycle
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Doxorubicin HCL
Dosage: days 1 and 2
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Ifosfamide
Dosage: dadys 1 and 2
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Mesna
Start date: 2011-09-21
Mesna
Mesna
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Navelbine
Indication: Rhabdomyosarcoma
Start date: 2012-03-01
Vincristine
Dosage: days 1, 8 and 15 of cycle
Indication: Sarcoma Metastatic
Start date: 2011-07-12
Other drugs received by patient: Ondansetron; Ondansetron; Levomepromazine; Docusate; Gentamycin Sulfate; Piperacillin and Tazobactam; Ondansetron; Neupogen; Levomepromazine; Docusate; Fluconazole; Docusate; Dihydrocodeine Bitartrate INJ; Ondansetron; Movicol / 01625101 /; Movicol / 01625101 /; Neupogen; Acetaminophen; Morphine; Movicol / 01625101 /; Cotrim
Possible Navelbine side effects in 79 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-04
Patient: 79 year old female
Reactions: Blood Pressure Increased, Vertigo
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Naloxone
Dosage: 5 mg tid
Indication: Pain
Start date: 2012-03-21
End date: 2012-03-28
Navelbine
Dosage: 2 mg iv
Indication: Breast Cancer
Start date: 2012-03-21
End date: 2012-03-21
|